Literature DB >> 24752674

Ethanol-Based Post-processing of Generator-Derived ⁶⁸Ga Toward Kit-Type Preparation of ⁶⁸Ga-Radiopharmaceuticals.

Elisabeth Eppard1, Michael Wuttke1, Philipp L Nicodemus1, Frank Rösch2.   

Abstract

UNLABELLED: Post-processing by means of a cation-exchanger-based protocol is an efficient strategy for purification and concentration of generator-derived (68)Ga. It ensures the removal of (68)Ge before (68)Ga-radiopharmaceutical preparation and high labeling yields of (68)Ga-labeled radiopharmaceuticals for routine medical application.
METHODS: In an effort to overcome the problem associated with acetone in the currently applied method, we have investigated the feasibility of replacing it with ethanol. The purification of (68)Ga from coeluted metallic impurities ((68)Ge(4+), Fe(3+), Zn(2+), and Ti(4+)) on various cation-exchange columns has been investigated with a variety of post-processing solutions. As a proof of principle, the post-processed (68)Ga was used to radiolabel DOTATOC in combination with high-purity water and various buffer solutions.
RESULTS: An effective protocol for the processing of generator-produced (68)Ga on the basis of cation-exchange chromatography using EtOH/HCl medium has been developed. Up to 95% of the initially eluted (68)Ga activity can be collected in a 1-mL fraction of 90% EtOH/0.9N HCl after removal of (68)Ge-breakthrough in a washing step. The post-processed eluate has been used to radiolabel DOTATOC in yields of approximately 97% ± 0.25% at 80°C in 5 min.
CONCLUSION: The described novel protocol improves the radiolabeling efficiency and efficacy of DOTATOC, providing yields of greater than 99% (decay-corrected). As a result, further purification to separate the desired product from uncomplexed (68)Ga is not necessary. The developed post-processing and labeling protocols permit reliable and high-yield preparation of injectable (68)Ga-DOTATOC (or other (68)Ga-labeled radiopharmaceuticals) that are suitable for routine application. It is possible to incorporate this protocol into existing automated modules.
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  68Ga; 68Ge; DOTATOC; ethanol; post-processing

Mesh:

Substances:

Year:  2014        PMID: 24752674     DOI: 10.2967/jnumed.113.133041

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  21 in total

1.  Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time.

Authors:  Euy Sung Moon; Sanjana Ballal; Madhav Prasad Yadav; Chandrasekhar Bal; Yentl Van Rymenant; Sarah Stephan; An Bracke; Pieter Van der Veken; Ingrid De Meester; Frank Roesch
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-12-15

2.  Synthesis, Physicochemical, Labeling and In Vivo Characterization of 44Sc-Labeled DO3AM-NI as a Hypoxia-Sensitive PET Probe.

Authors:  Dániel Szücs; Tibor Csupász; Judit P Szabó; Adrienn Kis; Barbara Gyuricza; Viktória Arató; Viktória Forgács; Adrienn Vágner; Gábor Nagy; Ildikó Garai; Dezső Szikra; Imre Tóth; György Trencsényi; Gyula Tircsó; Anikó Fekete
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-26

3.  Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets.

Authors:  Alexandra I Fonseca; Vítor H Alves; Sérgio J C do Carmo; Magda Silva; Ivanna Hrynchak; Francisco Alves; Amílcar Falcão; Antero J Abrunhosa
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-07

4.  Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling.

Authors:  Maria Iris Tsionou; Caroline E Knapp; Calum A Foley; Catherine R Munteanu; Andrew Cakebread; Cinzia Imberti; Thomas R Eykyn; Jennifer D Young; Brett M Paterson; Philip J Blower; Michelle T Ma
Journal:  RSC Adv       Date:  2017-10-25       Impact factor: 3.361

5.  Radiolabeling of DOTA-like conjugated peptides with generator-produced (68)Ga and using NaCl-based cationic elution method.

Authors:  Dirk Mueller; Wouter A P Breeman; Ingo Klette; Michael Gottschaldt; Andreas Odparlik; Manfred Baehre; Izabela Tworowska; Michael K Schultz
Journal:  Nat Protoc       Date:  2016-05-12       Impact factor: 13.491

6.  In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA5.SA.FAPi and DOTA.SA.FAPi.

Authors:  Euy Sung Moon; Yentl Van Rymenant; Sandeep Battan; Joni De Loose; An Bracke; Pieter Van der Veken; Ingrid De Meester; Frank Rösch
Journal:  Molecules       Date:  2021-06-08       Impact factor: 4.411

7.  New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.).

Authors:  Michelle T Ma; Carleen Cullinane; Cinzia Imberti; Julia Baguña Torres; Samantha Y A Terry; Peter Roselt; Rodney J Hicks; Philip J Blower
Journal:  Bioconjug Chem       Date:  2015-09-02       Impact factor: 4.774

8.  Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate.

Authors:  Michelle T Ma; Carleen Cullinane; Kelly Waldeck; Peter Roselt; Rodney J Hicks; Philip J Blower
Journal:  EJNMMI Res       Date:  2015-10-09       Impact factor: 3.138

9.  Uptake of PSMA-ligands in normal tissues is dependent on tumor load in patients with prostate cancer.

Authors:  Florian C Gaertner; Khalil Halabi; Hojjat Ahmadzadehfar; Stefan Kürpig; Elisabeth Eppard; Charalambos Kotsikopoulos; Nikolaos Liakos; Ralph A Bundschuh; Holger Strunk; Markus Essler
Journal:  Oncotarget       Date:  2017-07-06

10.  Labeling of DOTA-conjugated HPMA-based polymers with trivalent metallic radionuclides for molecular imaging.

Authors:  Elisabeth Eppard; Ana de la Fuente; Nicole Mohr; Mareli Allmeroth; Rudolf Zentel; Matthias Miederer; Stefanie Pektor; Frank Rösch
Journal:  EJNMMI Res       Date:  2018-02-27       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.